Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of RTS,S/AS01E Malaria Vaccine in Infants
NCT01231503Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2011
- Primary completion
- Apr 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of RTS,S in malaria, sponsored by GSK. Started Jan 2011; status: completed.
02
Drugs
RTS,S
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01231503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01231503.